实施证据为基础的剖宫产集束化措施可能不如预期有益:一项多中心实施前与实施后研究
该多中心实施前与实施后试验在4家教学医院比较了集束化循证剖宫产步骤与医生偏好对结局的影响,共分析1425例剖宫产。结果显示集束化实施后产妇复合发病率有轻度降低(校正相对风险0.88,95%可信区间0.73-1.04),但新生儿复合发病率出现paradoxical升高(校正相对风险1.12,95%可信区间0.98-1.39)。作者结论认为目前不推荐正式集束化这些步骤。
要点
- 集束化循证剖宫产步骤后产妇复合发病率有轻度降低,但未达统计学显著。
- 集束化实施后新生儿复合发病率出现paradoxical升高,95%可信区间0.98-1.39。
- 作者结论认为尽管个别循证步骤可能有益,目前不推荐正式集束化这些步骤。
核心结论
- 标准化集束化循证剖宫产步骤导致产妇复合结局轻度降低,但观察到新生儿复合发病率paradoxical升高。
- 作者认为尽管个别循证步骤可能有价值,目前不推荐正式集束化这些步骤。
研究设计与样本
- 遵循实施研究报告标准的多中心实施前与实施后试验,在4家教学医院进行。
- 实施前阶段为3个月基于医生偏好的剖宫产,第4个月进行教育干预,实施后阶段采用集束化循证步骤。
- 对两组进行预先计划的10%随机审计以评估依从性和循证步骤的采纳情况。
- 贝叶斯样本量计算表明每组需700例剖宫产,以75%确定性证明产妇复合发病率相对降低20%(从15%至12%)。
主要发现
- 共检查1425例连续剖宫产(实施前组721例,实施后组704例)。
- 审计数据显示实施前阶段基线循证步骤利用率为79%,实施集束化后审计依从率为89%,即循证步骤采纳率提高10.0%。
- 实施前组和實施後组产妇复合发病率分别为26%和22%(校正相对风险0.88,95%可信区间0.73-1.04),贝叶斯概率94%支持降低。
- 实施前组和實施後组新生儿复合发病率分别为37%和41%(校正相对风险1.12,95%可信区间0.98-1.39),贝叶斯概率95%支持恶化。
- 按早产(<37周)和足月(≥37周)剖宫产分层后,产妇结局改善持续存在;按孕龄亚组分层后,新生儿结局潜在恶化也持续存在。
临床怎么用
- 作者结论指出,尽管个别循证步骤可能有价值,目前不推荐正式集束化这些步骤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standardization of procedures improves outcomes. Though systematic reviews have summarized the evidence-based steps of cesarean delivery, their bundled implementation has not been investigated. OBJECTIVE: In this preimplementation and postimplementation trial, we sought to ascertain if bundled evidence-based steps of cesarean delivery, compared with the surgeon's preference, improve outcomes. STUDY DESIGN: A Standards for Reporting Implementation Studies compliant, multicenter preimplementation and postimplementation trial at 4 teaching hospitals was conducted. The preimplementation period consisted of cesarean delivery done on the basis of the physicians' preferences for 3 months; educational intervention (eg, didactics, badge cards, posters, video) occurred in the fourth month. Cesarean deliveries in the postimplementation period employed the bundled evidence-based steps. A preplanned 10% randomized audit of both groups assessed adherence and uptake of evidence-based steps. The primary outcome was composite maternal morbidity, which included estimated blood loss ≥1000 mL, blood transfusion, endometritis, postpartum fever, wound complications, sepsis, thrombosis, intensive care unit admission, hysterectomy, or death. The secondary outcome was composite neonatal morbidity, and some of its components were a 5-min Apgar score <7, positive pressure oxygen use, hypoglycemia, or sepsis. A priori Bayesian sample size calculation indicated 700 cesarean deliveries in each group were needed to demonstrate a 20% relative reduction (from 15% to 12%) of composite maternal morbidity with 75% certainty. Bayesian logistic regression with neutral priors was used to calculate the likelihood of net improvement in adjusted relative risk with 95% credible intervals. RESULTS: A total of 1425 consecutive cesarean deliveries (721 in preimplementation and 704 in postimplementation group) were examined. Audited data indicated that the baseline evidence-based steps utilization rate during the preimplementation period was 79%; after the implementation of bundled evidence-based steps of cesarean delivery, the audited adherence was 89%-an uptake of 10.0% of the evidence-based steps. In 4 aspects, the maternal characteristics differed significantly in the preimplementation and postimplementation periods: race/ethnicity, hypertensive disorder, and the relative contribution of the 4 centers to the cohorts and the gestational age at delivery, but the indications for cesarean delivery and whether its duration was less or greater than 60 minutes did not. The rates of composite maternal morbidity in the preimplementation and postimplementation groups were 26% and 22%, respectively (adjusted relative risk, 0.88 [95% credible intervals, 0.73-1.04]), with a 94 % Bayesian probability of a reduction in composite maternal morbidity. The composite maternal morbidity occurred in 37% of the preimplementation and 41% of the postimplementation group (adjusted relative risk, 1.12 [95% credible intervals, 0.98-1.39]), with a 95% Bayesian probability of worsening in composite maternal morbidity. When composite maternal morbidity was segregated by preterm (<37 weeks) and term (≥37 weeks) cesarean delivery, the improvement in maternal outcomes persisted; when composite maternal morbidity was segregated by gestational age subgroups, the potential for worsening neonatal outcomes persisted as well. CONCLUSION: Standardization of the evidence-based bundled steps of cesarean delivery resulted in a modest reduction of the composite maternal outcome; however, a paradoxical increase in neonatal composite morbidity was noted. Although individual evidence-based steps may be of value while awaiting additional intervention trials, a formal bundling of such steps is currently not recommended.
引用
- Huntley ES, Huntley BJF, Moreno MB, et al. Implementing a bundle for evidence-based cesarean delivery may not be as beneficial as expected: a multicenter, pre- and post-study. Am J Obstet Gynecol. 2024. PMID: 38599476. doi:10.1016/j.ajog.2024.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。